Table 1 Model performance metrics discriminating autism groups

From: Longitudinal EEG power in the first postnatal year differentiates autism outcomes

Models

Discrimination rate (CI95)

Sensitivity

Specificity

PPV

NPV

3–12 months

Frontal

 ASD vs. HRA-

89.1% (81.2–97.1%)

81.82

86.27

72

91.67

 ASD vs. LRC

91.0% (83.2–98.8%)

82.35

87.72

66.67

94.34

 HRA- vs. LRC

76.7% (67.7–85.7%)

81.25

61.4

63.93

79.55

Whole-head

 ASD vs. HRA−

81.7% (70.0–93.5%)

90.91

64.71

52.63

94.29

 ASD vs. LRC

80.3% (65.9–94.7%)

76.47

80.7

54.17

92

 HRA− vs. LRC

73.9% (64.6–83.3%)

54.17

82.46

72.22

68.12

Temporal-Parietal

 ASD vs. HRA−

83.4% (72.9–93.9%)

72.73

86.27

69.57

88

 ASD vs. LRC

82.2% (68.7–95.8%)

64.71

96.49

84.62

90.16

 HRA- vs. LRC

77.4% (68.6–86.3%)

64.58

78.95

72.09

72.58

12–24 months

Frontal

 ASD vs. HRA−

81.7% (71.6–91.8%)

80

75.56

64.52

87.18

 ASD vs. LRC

86.4% (76.0–96.8%)

90

70.45

58.06

93.94

 HRA− vs. LRC

74.8% (65.0–84.7%)

77.78

70

70

77.78

Whole-head

 ASD vs. HRA-

87.6% (78.8–96.5%)

70

93.48

82.35

87.76

 ASD vs. LRC

89.0% (78.9–99.1%)

85

87.5

73.91

93.33

 HRA- vs. LRC

80.0% (71.2–88.8%)

58.70

87.5

81.82

68.85

Temporal-Parietal

 ASD vs. HRA−

76.9% (66.2–87.6%)

80

65.31

54.05

86.49

 ASD vs. LRC

89.4% (81.3–97.4%)

90

75

60

94.74

 HRA- vs. LRC

80.9% (72.6–89.2%)

83.67

68.52

70.69

82.22

3–36 months

Frontal

 ASD vs. HRA−

86.7% (78.1–95.3%)

84

81.54

63.64

92.98

 ASD vs. LRC

87.0% (77.2–96.8%)

84

80.65

63.64

92.59

 HRA− vs. LRC

81.1% (73.8–88.4%)

72.31

74.19

74.6

71.88

Whole-head

ASD vs. HRA−

87.7% (79.5–95.9%)

84

84.62

67.74

93.22

ASD vs. LRC

85.7% (74.9–96.6%)

80

90.32

76.92

91.80

HRA− vs. LRC

77.5% (69.4–85.5%)

69.23

75.80

75

70.15

Temporal-Parietal

ASD vs. HRA−

83.6% (75.1–92.2%)

67.74

85.92

67.74

85.92

ASD vs. LRC

87.0% (77.5–96.6%)

84

83.87

67.74

92.86

HRA− vs. LRC

75.2% (66.8–83.7%)

72.31

72.58

73.44

71.43

  1. Evaluated at Youden’s index maximum
  2. CI95 95% confidence interval around the estimate, PPV positive predictive value (true positive outcome percentage), NPV negative predictive value (true negative outcome percentage)